Peptide Comparison
CJC-1295 vs Tesamorelin
CJC-1295 and tesamorelin are both long-acting GHRH analogs. Tesamorelin carries an FDA approval for visceral fat reduction; CJC-1295 is used off-label or as a compounded preparation for GH optimization.
CJC-1295
CJC-1295 is a synthetic GHRH analog. See the TruthTides evidence library for graded study summaries, pharmacokinetic data, and citations.
CJC-1295 Clinical ReferenceTesamorelin
Tesamorelin is an FDA-approved synthetic GHRH analog indicated for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. It stimulates physiological growth hormone secretion and has demonstrated significant visceral adipose tissue reduction in clinical trials.
Tesamorelin Clinical ReferenceKey Differences
This comparison is informational and reflects content from TruthTides clinical reference documentation. It does not constitute medical advice. Only three peptides on TruthTides — semaglutide, tirzepatide, and tesamorelin — carry FDA approvals; many others are compounded or off-label. Consult a qualified physician before starting any peptide therapy.
Ask TruthSource AI
Which is right for me — CJC-1295 or Tesamorelin?
Get a guardrailed, evidence-anchored answer based on your goals.
Open Reference ToolFind a Doctor
Find a physician who prescribes CJC-1295 or Tesamorelin
Filter our directory by peptide, location, and telehealth availability.
Open Physician Finder